Organigram Global Inc. (OGI) exceeds Q1 revenue expectations, reporting $97.3 million compared to the consensus of $73.15 million. Adjusted EBITDA rose to $5.3 million from $1.4 million last year. Canaccord covers OGI with a Buy rating, highlighting its global market leadership in various cannabis products. The company aims for continued international expansion.

Read more at Yahoo Finance: Organigram Global Inc. (OGI) Reports Q1 Revenue of $97.3 Million, with a Consensus of $73.15 Million